Teva Unit Urges Fed Circ. To Revive ADHD Drug Row
A Teva unit has urged the Federal Circuit to review a lower court's remand decision that held that its proposed generic version of ADHD treatment Quillivant XR infringed five valid Tris...To view the full article, register now.
Already a subscriber? Click here to view full article